The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $65.61

Today's change0.00 0.00%
Updated December 17 4:02 PM EST. Delayed by at least 15 minutes.
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $65.61

Today's change0.00 0.00%
Updated December 17 4:02 PM EST. Delayed by at least 15 minutes.

St. Jude Medical Inc closed at (U.S.)$65.61.

Shares have lost 1.97% over the last five days, but have gained 5.91% over the last year to date. This security has underperformed the S&P 500 by 2.60% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $65.61
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+5.91%
  • Volume0
  • Average volume (10-day)1,781,424
  • Average volume (1-month)1,850,478
  • Average volume (3-month)1,931,547
  • 52-week range(U.S.) $54.80 to (U.S.) $71.90
  • Beta1.32
  • Trailing P/E21.65×
  • P/E 1 year forward16.49×
  • Forward PEG2.08×
  • Indicated annual dividend(U.S.) $1.08
  • Dividend yield1.65%
  • Trailing EPS(U.S.) $3.03
Updated December 17 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.77%

Based on its net profit margin of 14.77%, St. Jude Medical Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.54%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 28, 201312/28/2013
Revenue1,3721,4481,3631,422
Total other revenue--------
Total revenue1,3721,4481,3631,422
Gross profit9841,0419811,016
Total cost of revenue388407382406
Total operating expense1,1021,1591,0511,274
Selling / general / administrative461492465475
Research & development169178170186
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)848234207
Other operating expenses, total--------
Operating income270289312148
Interest income (expense), net non-operating-21-21-21-21
Gain (loss) on sale of assets--------
Other--------
Income before tax250268292129
Income after tax232246239111
Income tax, total18225318
Net income238270249123
Total adjustments to net income--------
Net income before extra. items238270249123
Minority interest6241012
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items238270249123
Inc. avail. to common incl. extra. items238270249123
Diluted net income238270249123
Dilution adjustment----0--
Diluted weighted average shares290289289296
Diluted EPS excluding extraordinary itemsvalue per share0.820.930.860.42
Dividends per sharevalue per share0.270.270.270.25
Diluted normalized EPSvalue per share1.091.200.960.01